Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plan B Ruling: Little Commercial Impact, Big Policy Implications

This article was originally published in The Tan Sheet

Executive Summary

The court ruling overturning FDA's restricted distribution of the emergency contraceptive Plan B could have a number of implications for the biopharma industry - ranging from a near-term impact on confirmation of Obama administration nominees to a longer-term curbing of creative product risk management activities

You may also be interested in...



Comments Make Clear Jewish Women’s Group Supports OTC Daily Oral Contraceptive Approval

Religious groups commonly respond to proposals in US for birth control drugs or services, usually in opposition. But members of the National Council of Jewish Women are using form letters for comments supporting making a daily oral contraceptive drug available OTC.

Age-Restriction Labeling, Behind-The-Counter Sales Likely In HRA's US OTC Contraceptive NDA

“I think the issue is whether it is going to have age restricted labeling, which would be a political issue rather than a medical issue,” says 

Political Winds, Like Previous Storms Over US FDA Decisions, Stir Around OTC Contraceptive Proposal

Experts spoke with HBW Insight about potential impact on US contraceptive market from Supreme Court’s decision in Dobbs v. Jackson overturning its 1973 ruling in Roe v. Wade, which was upheld in 1992 ruling in Planned Parenthood v. Casey, stating a woman has a constitutional right to reproductive health services.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS102756

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel